-->

Phospho-STING (Ser366) Cellular Kit HTRF®

This HTRF kit enables the cell-based quantitative detection of phosphorylated STING as a readout of the activation of the cGAS-STING pathway

See more
  • No-wash No-wash
  • High sensitivity High sensitivity
  • All inclusive kit All inclusive kit
  • Low sample consumption Low sample consumption

This HTRF kit enables the cell-based quantitative detection of phosphorylated STING as a readout of the activation of the cGAS-STING pathway

-

Overview

This HTRF cell-based assay conveniently and accurately quantifies phosphorylated STING at Ser366. Following pathogen infection and binding of dsDNA to the cytoplasmic sensor cGAS, STING protein is phosphorylated by TBK1, enabling its binding to IRF3 which induces IFNs type 1 production. The STING pathway is then switched off by STING degradation involving autophagy. In immuno-oncology, activating the STING pathway has shown promising anti-tumor effects in pre-clinical models and thus represents a therapeutic strategy to treat human cancer.

Benefits

  • SPECIFICITY
  • PRECISION

Phospho-STING (Ser366) assay principle

The Phospho-STING (Ser366) assay measures STING when phosphorylated at Ser366. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer. The Phospho-STING (Ser366) assay uses 2 labeled antibodies: one with a donor fluorophore, the other one with an acceptor. The first antibody is selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving the two labeled antibodies and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein's phosphorylation state under a no-wash assay format.

phospho-sting-y641-assay-principle

Phospho-STING (Ser366) two-plate assay protocol

The two-plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a low volume detection plate (either HTRF 384-lv or 96-lv plate) before adding HTRF Phospho-STING (Ser366) detection reagents. This protocol enables the cells' viability and confluence to be monitored.

total-sting-2-plate-assay-protocol

Phospho-STING (Ser366) one-plate assay protocol

Detection of Phosphorylated STING (Ser366) with HTRF reagents can be performed in a single plate used for culturing, stimulation and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
total-sting-1-plate-assay-protocol

1. 2’-3’ cGAMP induces STING phosphorylation in THP1 cells

Human THP1-R232 cells (from Invivogen) were plated under 25µl in a 96-well plates (400,000 cells/well) in complete culture medium. The cells were stimulated with increasing concentrations of 2’3’cGAMP (5µL for 4 hours). Cells were then lysed with the addition of 10 µL of supplemented lysis buffer #4 at 4X for 30 minutes at RT under gentle shaking. 16 µL of lysate were transferred into a 384 low volume white microplate before adding 4 µL of the HTRF phospho-STING or total STING detection antibodies. In addition, Alpha-tubulin housekeeping protein was analyzed from 4 µL of cell lysate using the corresponding HTRF alpha-tubulin housekeeping kit. Finally, HTRF signals were recorded after an overnight incubation at RT. As described elsewhere, 2’3’cGAMP induced a significant activation of the STING pathway, leading to a 6-fold increase of STING phosphorylation. Induced STING phosphorylation was associated with a down-regulation of its expression level, in agreement with autophagy mediated degradation, whereas alpha-tubulin remained stable under the same conditions

Validation of the HTRF HTRF Phospho & Total STING on THP1-R232 cells treated with cGAMP
Validation of the HTRF HTRF Alpha tubulin assay on THP1-R232 cells treated with cGAMP

HTRF Phospho and total STING enable accurate quantification of agonist-induced STING regulation.

400,000 THP1-R232 cells (from Invivogen) were plated under 25µl in 96-well plates in complete culture medium. The cells were stimulated with increasing concentrations of 2’3’cGAMP (5µL for 4 hours). Cells were then lysed with the addition of 10 µL of supplemented lysis buffer #4 at 4X for 30 minutes at RT under gentle shaking. 16 µL of lysate were analyzed either by HTRF or by Western Blot, in parallel.Signal quantification by HTRF enabled accurate statistical analysis of compound effects, as shown on the graphs below, where 400µM of cGAMP significantly decreased both total and phospho-STING (statistical method used: One way-Anova, P value < 0.0001).

Validation of the HTRF Phospho STING assay on THP1-R232 cells treated with cGAMP
Validation of the HTRF total STING assay on THP1-R232 cells treated with cGAMP

HTRF phospho-STING cellular assays compared to Western Blot

The human THP1-R232 cell line was seeded in a T175 flask in complete culture medium, and incubated for 2 days at 37°C, 5% CO2. Cells were then stimulated with 100 µM 2’3’cGAMP for 4 hours and lysed with 3 mL of supplemented lysis buffer #4 for 30 minutes at RT under gentle shaking. Soluble supernatants were collected after a 10-minute centrifugation.Serial dilutions of the cell lysate were performed in the supplemented lysis buffer and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF phospho-STING detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.

Using the HTRF Phospho-STING assay, only 4,000 cells/well were sufficient to detect a significant signal while 63,000 cells were needed for minimal ECL signal detection using Western Blot. Therefore, in our experiment the HTRF phospho-STING assay was 16 times more sensitive than the Western Blot.

Comparison between western blot and HTRF Phospho STING assay on THP1-R232 cells stimulated with cGAMP

STING simplified pathway

STING, for STimulator of INterferon Genes, is a cytoplasmic homodimeric protein localized in the endoplasmic reticulum and which plays an essential role in innate immunity. Upon pathogen infection or mitochrondrial shrinking during apoptosis, floating dsDNAs bind and activate a DNA sensor, the cyclic GMP-AMP synthase (cGAS). Activated cGas leads to the production of 2’-3’cGAMP, a cyclic dinucleotide, which then binds to STING proteins. In turn, phosphorylated STING interacts with TANK-binding-kinase-I (TBK1) leading to the recruitment and activation of active interferon regulatory factor (IRF3) dimer. Nuclear translocation of IRF3 dimer leads to the transcription of genes encoding IFN-α/β. In addition, the STING pathway controls NF-κB dependent inflammatory cytokine expression. As a negative feedback loop, the DNA-stimulated cGAS-STING-TBK1 pathway also triggers STING protein degradation through p62 SQSTM1 associated autophagy, switching off IFNβ production.
Pathway STING phospho

HTRF phospho-assays reveal subtle drug-induced effects

Detailed protocol and direct comparison with WB - Posters

HTRF® cell signaling platform combined with iCell® Hepatocytes

A solution for phospho-protein analysis in metabolic disorders - Posters

Key guidelines to successful cell signaling experiments

Mastering the art of cell signaling assays optimization - Guides

Optimize your HTRF cell signaling assays on tissues

HTRF and WB compatible guidelines - Technical Notes

HTRF Alpha-tubulin Housekeeping kit

Properly interpret your compound effect - Application Notes

Best practices for analyzing brain samples with HTRF® phospho assays for neurosciences

Insider Tips for successful sample treatment - Technical Notes

HTRF phospho-total lysis buffer: a universal alternative to RIPA lysis buffers

Increased flexibility of phospho-assays - Application Notes

HTRF cell-based phospho-protein data normalization

Valuable guidelines for efficiently analyzing and interpreting results - Application Notes

HTRF phospho assays reveal subtle drug induced effects in tumor-xenografts

Tumor xenograft analysis: HTRF versus Western blot - Application Notes

Best practices for analyzing tumor xenografts with HTRF phospho assays

Protocol for tumor xenograft analysis with HTRF - Technical Notes

Unleash the potential of your phosphorylation research with HTRF

Unmatched ease of use, sensitivity and specificity assays - Videos

How to run a cell based phospho HTRF assay

What to expect at the bench - Videos

TCR signaling investigation with HTRF phospho assays

Study a pathway of interest in PBMC and T cells - Application Notes

Universal HTRF® phospho-protein platform: from 2D, 3D, primary cells to patient derived tumor cells

Analysis of a large panel of diverse biological samples and cellular models - Posters

Simplified pathway dissection with HTRF phospho-assays and CyBi-felix liquid handling

Analyse of PI3K/AKT/mTor translational control pathway - Application Notes

Investigating kinase activity in a cellular context

HTRF cellular assays - Scientific Presentations

Species compatibility

Cell Signaling: Biomarkers, Phospho- & total-protein assays - Flyers

Inflammation cell by cell

HTRF solutions for each cell type - Flyers

HTRF cellular phospho-protein assays

Physiologically relevant results fo fast flowing research - Flyers

Lysis buffer compatibility

Cell Signaling: Biomarkers, Phospho- & total-protein Assays - Flyers

Open R&D: Sanofi Access Platform

In collaboration with Sanofi - Scientific Presentations

Biomarker and Cell Signaling Assays for Fibrosis and NASH

HTRF and Alpha solutions for NASH - Flyers

STING HTRF offer to bridge innate and adaptive immunity

cGAS-STING signaling pathway from A to Z - Brochures

HTRF Product Catalog

All your HTRF assays in one document! - Catalog

A guide to Homogeneous Time Resolved Fluorescence

General principles of HTRF - Guides

STING, the next candidate for cancer immunotherapy

Infographic about STING protein - Infographics

STING variants charaterization

Unlock STING polymorphism with this valuable note - Application Notes

How HTRF compares to Western Blot and ELISA

Get the brochure about technology comparison. - Brochures

Unleash the potential of your phosphorylation research with HTRF

A fun video introducing you to phosphorylation assays with HTRF - Videos

How to run a cell based phospho HTRF assay

3' video to set up your Phospho assay - Videos

Characterize STING agonists with HTRF human IFNb

Data about HTRF IFNb correlation with gene reporter assay and ELISA - Application Notes

An innate and adaptive immunity recap

Insight into the diversity of cells & signaling pathways - Guides

Immuno-Oncology Drug Discovery

Explore our solutions for Immuno-oncology research - Flyers

Assays for autoimmunity research

Advance your research on autoimmune diseases - Flyers

Advance your research on Fibrosis

Kits and reagents for Fibrosis research - Flyers

Guidelines for Cell Culture and Lysis in Different Formats Prior to HTRF Detection

Seeding and lysing recommendations for a number of cell culture vessels. - Technical Notes

Assessment of drug efficacy and toxicity by combining innovative technologies

Combination of AlphaLISA®, HTRF®, or AlphaLISA® SureFire® Ultra™ immunoassays with the ATPlite™ 1step cell viability assay - Application Notes

Methodological Aspects of Homogeneous Time-Resolved Fluorescence (HTRF)

Learn how to reduce time and sample consumption - Application Notes

Plate Reader Requirement

Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.

Let's find your reader